Current status in cancer cell reprogramming and its clinical implications
Crossref DOI link: https://doi.org/10.1007/s00432-016-2258-5
Published Online: 2016-09-12
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Izgi, Kenan
Canatan, Halit
Iskender, Banu
Funding for this research was provided by:
The Scientific and Technological Research Council of Turkey (114S452, 113S927)
License valid from 2016-09-12